Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma

被引：0
作者：
Wenting Liu
Qingwu Du
Ting Mei
Jingya Wang
Dingzhi Huang
Tingting Qin
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Thoracic Oncology, Tianjin Key Laboratory of Cancer Prevention and Therapy
[2] National Clinical Research Center for Cancer,undefined
[3] Tianjin’s Clinical Research Center for Cancer,undefined
来源：
BMC Cancer | / 24卷
关键词：
SFXN1; Lung adenocarcinoma; Biomarker; Prognosis; Tumor immune microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 184 条
  • [1] Siegel RL(2023)Cancer statistics, 2023 CA Cancer J Clin 73 17-48
  • [2] Miller KD(2008)Non-small cell Lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 584-594
  • [3] Wagle NS(2003)Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents Oncogene 22 6629-6638
  • [4] Jemal A(2017)EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell Lung cancer Oncotarget 8 75712-75726
  • [5] Molina JR(2015)Personalised cancer medicine Int J Cancer 137 262-266
  • [6] Yang P(2015)The evolution of therapies in non-small cell lung cancer Cancers (Basel) 7 1815-1846
  • [7] Cassivi SD(2011)Hallmarks of cancer: the next generation Cell 144 646-674
  • [8] Schild SE(2015)Mitochondria in the regulation of innate and adaptive immunity Immunity 3 406-417
  • [9] Adjei AA(2014)Mitochondrial dynamics: biology and therapy in lung cancer Expert Opin Investig Drugs 23 675-692
  • [10] Gridelli C(2020)Mitochondrial metabolism as a target for cancer therapy Cell Metab 32 341-352
12345678910